Citius Oncology, Inc. CTOR Stock Issued During Period Shares Proceeds From Exercise Of Prefunded Warrantsin Shares
Other financials
Where this comes from
Reported directly by Citius Oncology, Inc. in its filing.
Tagged under the XBRL concept ctor:StockIssuedDuringPeriodSharesProceedsFromExerciseOfPrefundedWarrantsinShares.
The official record: Citius Oncology, Inc.’s 10-Q, filed May 15, 2026, on SEC EDGAR. View the filing →
Ask your AI about Citius Oncology, Inc.'s stock issued during period shares proceeds from exercise of prefunded warrantsin shares.
Connect your AI assistant and see it in context, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Citius Oncology, Inc.'s stock issued during period shares proceeds from exercise of prefunded warrantsin shares?
- Citius Oncology, Inc. (CTOR) reported stock issued during period shares proceeds from exercise of prefunded warrantsin shares of 8.2M in Q1 2026.